| CAT No: | CL-PXF-09 |
| CAS No: | 771464-86-9 |
| Mol.F: | C46H84N12 |
| Mol.Wt.: | C46H84N12 |
| Chemical Name: | 1,11-Bis(4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzyl)-1,4,8,11-tetraazacyclotetradecane |
| Inventory Status: | Custom synthesis |
This impurity is related to Plerixafor Impurity 8 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Plerixafor Impurity 8 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name: 1,11-Bis(4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzyl)-1,4,8,11-tetraazacyclotetradecaneCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Plerixafor Molecular Formula: C46H84N12
Molecular Weight: C46H84N12
Storage: Store in a cool, dry place.
| Product Name: | Plerixafor Impurity 8 |
| CAS No: | 771464-86-9 |
| Mol.F.: | C46H84N12 |
| Mol.Wt.: | C46H84N12 |
Cat. No: CL-PXF-01
CAS No: 110078-46-1
Mol. F: C28H54N8
Mol. Wt: 502.8
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-02
CAS No: 548488-49-9
Mol. F: C12H23F3N4O
Mol. Wt: 296.3
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-03
CAS No: NA
Mol. F: C14H22F6N4O2
Mol. Wt: 392.3
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-04
CAS No: NA
Mol. F: C14H22F6N4O2
Mol. Wt: 392.3
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-05
CAS No: 548488-50-2
Mol. F: C14H22F6N4O2
Mol. Wt: 392.3
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-06
CAS No: 201610-16-4
Mol. F: C18H20F12N4O4
Mol. Wt: 584.4
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-07
CAS No: NA
Mol. F: C29H54N8
Mol. Wt: 514.8
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-08
CAS No: 414858-02-9
Mol. F: C46H84N12
Mol. Wt: 805.3
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-10
CAS No: 2731552-39-7
Mol. F: C46H84N12
Mol. Wt: 805.3
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-01
CAS No: NA
Mol. F: C28H48N14O6
Mol. Wt: 676.8
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-02
CAS No: NA
Mol. F: C28H53N9O
Mol. Wt: 531.8
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-03
CAS No: NA
Mol. F: C28H53N9O
Mol. Wt: 531.8
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-04
CAS No: NA
Mol. F: C28H53N9O
Mol. Wt: 531.8
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-05
CAS No: NA
Mol. F: C29H48N14O6
Mol. Wt: 688.8
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-06
CAS No: NA
Mol. F: C46H76N20O8
Mol. Wt: 1037.2
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-07
CAS No: NA
Mol. F: C46H76N20O8
Mol. Wt: 1037.2
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-08
CAS No: NA
Mol. F: C29H48N14O6
Mol. Wt: 688.8
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-09
CAS No: NA
Mol. F: C18H29N7O3
Mol. Wt: 391.5
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-10
CAS No: NA
Mol. F: C17H27N7O4
Mol. Wt: 393.4
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-11
CAS No: NA
Mol. F: C10H20N8O4
Mol. Wt: 316.3
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-12
CAS No: NA
Mol. F: C29H48N14O6
Mol. Wt: 688.8
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-13
CAS No: NA
Mol. F: C24H43ClN8O3
Mol. Wt: 527.1
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-14
CAS No: NA
Mol. F: C26H46N14O6
Mol. Wt: 650.7
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-15
CAS No: NA
Mol. F: C18H27N7O4
Mol. Wt: 405.5
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-16
CAS No: NA
Mol. F: C18H27N7O4
Mol. Wt: 405.5
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-17
CAS No: NA
Mol. F: C25H54Cl8N12O4
Mol. Wt: 870.4
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-18
CAS No: NA
Mol. F: C10H20N8O4
Mol. Wt: 316.3
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-19
CAS No: NA
Mol. F: C24H34N6O6S2
Mol. Wt: 566.7
Inv. Status: Custom Synthesis
Cat. No: CL-PXF-NO-20
CAS No: NA
Mol. F: C28H48N14O7
Mol. Wt: 692.8
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: